The study indicated that the impact of inhibiting follicular helper T cells and B cells on tumor immune response is more profound than that of inhibiting CD8+ T cells, indicating that B cells and follicular helper T cells play a critical role in tumor immune response (Hollern et al., 2019). The gene discussed is CD8A; the disease is neoplasm.